-
Billion dollar market is being leveraged: Johnson&Johnson's two acquisitions in half a month only drive market reshuffle for atopic dermatitis?
On May 28th, Johnson&Johnson announced a final agreement with Numab Therapeutics to acquire its subsidiary Yellow Jersey Therapeutics for approximately $1.25 billion in cash, in order to acquire glob ... -
Sanofi responds to suspension of two flu vaccines: flu concept stocks rise for preventive measures only
Red Star Capital Bureau reported on August 27th that on the night of August 26th, major WeChat groups reported that the Pasteur influenza vaccine (trivalent and quadrivalent) under Sanofi had been su ...